What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

The objective of this research was to examine treatment patterns and health-care costs associated with second-step pharmacotherapy in patients with major depressive disorder (MDD) who initiated monotherapy with a selective serotonin reuptake inhibitor (SSRI) in 2010. This claims database study analy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of general psychiatry 2014-03, Vol.13 (1), p.8-8
Hauptverfasser:	Ball, Susan, Classi, Peter, Dennehy, Ellen B
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Comorbidity Drug therapy Insurance coverage Intervention Mortality Patients Physicians Primary Research Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!